endocrine condition and the possible wide range of phenotype and genotype within single families. Background: The rate at which new cases of Type 1 diabetes (T1D) in youth b 20 years old is increasing in the U.S. is a mounting pediatric public health concern; and age, race and ethnicity have significant impacts. Specific social determinants of health and sociodemographic (SD) characteristics -racial/ethnic minority, low SES, single parent home and underinsured-have consistently been associated with poorer glycemic control (GC) and self-management (SM) in adolescents with T1D. Purpose: The purpose of this systematic review was to evaluate sample demographics, and culturally responsive recruitment and reporting methods used in psychosocial and behavioral interventions focused on improving SM and GC in adolescents with T1D, to identify if studies were targeting these high risk groups and if current methods were being tailored to reach them. Description of Topic: Using a social determinants of health and health equity theoretical perspective, this review applied a culturally responsive research (CRR) framework to evaluate relevant interventions. Intervention studies, from 2006 to 2016, focused on adolescents (13-18yo) with T1D and improving SM and GC by psychosocial or behavioral methods, obtained from PsychInfo, PubMed and CINAHL, were evaluated using a CRR rubric. Twenty-eight studies met inclusion criteria; 14 reported on fewer than 3 of 7 SD categories. Of those that reported, overall study samples used convenience sampling methods, focused predominantly on white, middlehigh income, moderately GC'd adolescents from two-parent households with private insurance. Majority of studies scored poorly in cultural responsiveness in reporting analysis and interpretation, and moderately in culturally responsive reporting of SD descriptions of participants. Overall, studies lacked detailed recruitment and sampling methods, as relates to cultural inclusivity, neglecting to apply deliberate recruitment efforts and use of culturally responsive assessments for difficult to reach high risk groups. Clinical Implications: Pediatric endocrinology nurse interventionists must increase targeted efforts towards recruiting and sampling more high risk groups, by devising successful, culturally responsive methods of recruitment and sampling through community based participatory research, and including expanded SD reporting. These efforts will engage high risk participants and improve existing and novel interventions by making them relevant to the unique needs, goals and priorities of highest risk SD groups within pediatric endocrinology.
Background: The social and physical contexts which make up the social determinants of health (SDOH) have tremendous impacts on youth development, health and well-being, especially for youth with chronic conditions. Many youth and families affected by SDOH also experience significant overlap of multiple health related social problems, and the stress of these SDOH can exacerbate existing chronic conditions, or spur new conditions. Despite knowledge and evidence of the impact of SDOH on pediatric health, clinicians rarely screen for, or address, SDOH in pediatric clinical settings and few SDOH screening tools are known for use in pediatrics. Purpose: To gain a better understanding of the scope of pediatric SDOH screening tools, an integrative review of the literature was conducted. Its purpose was to identify available SDOH screening tools used in pediatric settings, and evaluate their comprehensiveness and validity in assessing multiple SDOH. Description of Topic: A systematic search of 3 online databases yielded 499 articles. Thirteen articles relevant to the assessment of SDOH were evaluated and appraised using the five domain SDOH framework outlined by Healthy People 2020. Majority of studies were limited in the number of SDOH domains screened and the depth of screening. Tools were heterogeneous in methods used to assess SDOH risks and few were validated. Limited number of studies included youth or families in the initial development of tools. Clinical Implications: Despite growing recognition across healthcare communities that SDOH greatly influence pediatric chronic disease health risks, management and outcomes, there is a dearth of available high quality, multidimensional, comprehensive screening tools for pediatric nurses and care professionals. This review emphasizes the need for continued development of comprehensive and effective tools for assessing pediatric SDOH risk factors. Without assessing the multiple layers of risks, care plans may be practically and materially infeasible for families to follow, despite a family's willingness. Pediatric endocrine nursing care includes the assessment of the youth and family context in order to effectively evaluate resource needs. Therefore, pediatric endocrine nurses are well poised to address this knowledge and resource gap to improve the lives of the youth and families they serve. Background: Through collaboration within the Canadian Pediatric Endocrine Nurses (CPEN) network it has become evident that there are differences in practices in the use of injectable testosterone for hypogonadal and transgender males. Some clinics in Canada offer Testosterone injections subcutaneously following a pilot study conducted at McGill University Health Center in 2006 reporting its safe use and efficacy. Purpose: CPEN Nurses across 15 clinical centers in Canada have explored current prescribing, monitoring and teaching practices for injectable testosterone through an online survey. Results of this survey, patient reports and a review of the current literature will inform future best practice as it relates to injectable testosterone in youth. Description of Topic: Intramuscular testosterone injections have been used since the 1940′s. A change to subcutaneous administration was first described in 2006 due to the inconvenience and discomfort of monthly intramuscular dosing. Currently recommended dosing of Depot Testosterone can be divided into weekly or biweekly subcutaneous doses. Due to testosterone's viscosity, the vial and the syringe are warmed in the patients' palms or axilla for at least 5 min. This allows for easier withdrawal of the medication from the vial, quicker and more comfortable injections. We expect patients will report a preference for subcutaneous administration and may gain independence much earlier in their treatment regime. Clinical Implications: For youth who are requiring injectable testosterone, subcutaneous administration can lower the experiences of pain, provide more constant levels of testosterone and allow for easier self-injections. Once initial education has been completed and the patient is independent, fewer injections will need to be given by nurses or other health care providers in clinics, day units and at times pharmacies. This provides for anonymity and privacy for patients who can do the injections in the privacy of their home, thus decreasing the need to answer potentially unwanted questions especially for the transgender youth. Background: Children can be diagnosed with a disorder of sex development (DSD) at birth with ambiguous genitalia, or later in childhood after investigations of other symptoms. In all cases, the diagnosis comes as a surprise, and there is initial parental distress and uncertainty about their child's future. The diagnosis of DSD can have a significant impact on the psychosocial development and wellbeing of the child, with challenges around diagnosis complexity, sex of rearing, uncertain outcomes, treatment options and psychological stressors. Purpose: Whilst disclosure in practice often occurs in a gradual manner when working within a multidisciplinary team, we propose to formalise a guidance system describing a developmentally staged approach. The process involves sequential information about body parts, differences between male and female, the wide potential for gender roles and later the potential for different individual development of sex, gender, sexuality and fertility. Description of Topic: The development of gender identity begins after the first year of life, with children generally identifying with one sex by age three. Self-awareness regarding identity and gender role evolves during childhood, with sexuality developing through adolescents, along with physical secondary sex characteristics. Critical psychological development also starts to occur, including the capacity to understand concepts such as future fertility potential. Therapeutic events such as genital surgery or requirement for sex hormone therapy can affect this process. Information provided to a child about their diagnosis therefore needs to be age appropriate, and tailored to the individual's developmental needs. Criticism of past DSD management has been poor or late disclosure of diagnosis to the young person, and although advice now supports earlier disclosure, there is limited literature guiding a method for this. Clinical Implications: The goal of treatment is to ensure that the child's psychological, physical and sexual well-being are supported in a respectful and appropriate manner. This can be achieved via a multidisciplinary team working with the parents to support the child, communicating honestly and respectfully to maintain trust, and providing guided appropriate information through defined developmental stages from infancy to adolescence and adulthood. The paediatric endocrine nurse plays a critical role in this process as both child's advocate and family educator. Background: Congenital Hyperinsulinism (CH) is caused by unregulated, increased secretion of insulin from the pancreatic beta cells. This results in severe persistent hypoglycemia which can lead to brain injury. Diffuse disease can be treated medically. Previous practice at SickKids was to treat patients with diffuse disease who did not respond to oral diazoxide and who declined pancreatectomy or had persistent hyperinsulinism post-pancreatectomy with subcutaneous octreotide injected every 8 h. There have been some studies that conclude long acting somatostatin analogue (Lanreotide) is a safe and effective alternative to octreotide therapy in CH patients with a significant improvement in blood glucose (BG) control and quality of life. Background: Most health professionals are aware that the incidence of obesity in the pediatric population is rising. This is a largely preventable health problem with multifactorial causes that health care professionals are increasingly called upon to manage. Because there is no widely accepted referral path for obesity and patients may have endocrine consequences of poor lifestyle habits, endocrine clinics are frequently receiving referrals for these patients. Purpose: The purpose of this poster is to share information on a program experience that targeted improved management of obese patients, with goals to increase adoption of healthy habits and a decline in no-show rates. Methods used, problems encountered, and suggestions for management of obese patients will be presented.
